-
Most cases of thrombocytopenia seen in the emergency department (ED) are expected. Patients are known to have hematological disease or are receiving chemotherapy. At times, however, the ED physician is confronted with an unexpected laboratory finding in an assymptomatic patient, or with a patient who is bleeding. The challenge, as usual, is to determine the need for acute treatment and the appropriate disposition.
-
-
Prompt, accurate assessment of the severity of injury and early initiation
of appropriate critical care — including adequate oxygenation,
ventilation and correction of hypotension — is of crucial importance
in preventing deaths in children with severe trauma. This article reviews
the critical aspects of airway assessment and management in the pediatric
trauma patient.
-
-
FDA recently announced these approvals: Novartis' Tasigna® (nilotinib) capsules has been approved by FDA for treating Philadelphia chromosome positive chronic myeloid leukemia in adults.
-
A federal judge suspended controversial Washington State rules that required pharmacies to dispense the Plan B emergency contraceptive.
-
The American Society of Health-System Pharmacists (ASHP) says pharmacists in hospitals and health systems are ready to play an expanded role in patient care and medication therapy if FDA decides to designate certain prescription-only drugs as behind-the-counter (BTC) drugs.
-
Researchers at Creighton University Medical Center and the School of Pharmacy and Health Professions have found that using prefilled disposable insulin pens rather than conventional vials and syringes in hospitalized diabetic patients led to greater patient satisfaction and cost savings.
-
It is a well-known fact that as we get older, our bones lose mass and become increasingly weaker.
-
FDA asked Bayer Pharmaceuticals Corp. to suspend marketing of Trasylol®, used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study suggesting an increased risk for death.